Supriya Lifescience targets Rs 1,600-cr revenue in three years on capacity expansion

Supriya Lifescience plans to reach Rs 1,600 crore revenue in three years. New facilities in Lote MIDC and Ambernath will drive this growth. The company focuses on niche, complex APIs, moving away from mass-volume products. New product launches and contract manufacturing tie-ups are also planned. Supriya Lifescience is debt-free, funding expansion through internal accruals.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QerLS2v
via IFTTT